Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
The New England Journal of Medicine|May 25, 1978
Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptorsR S Bar, W R Levis, M M Rechler, et al.Clinical Immunology and Immunopathology|November 1, 1989
IgA antibodies against phenolic glycolipid I from Mycobacterium leprae in serum of leprosy patients and contacts: subclass distribution and relation to disease activityB Schwerer, C S Chujor, H Bernheimer, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1987
Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitroG Kaplan, R R Gandhi, D E Weinstein, et al.Journal of the American Academy of Dermatology|September 1, 1986
Treatment of basal cell carcinoma with intralesional interferonH T Greenway, R C Cornell, D J Tanner, et al.Archives of Dermatology|August 1, 1990
The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomasL Edwards, S B Tucker, D Perednia, et al.The New England Journal of Medicine|July 3, 1986
Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosyC F Nathan, G Kaplan, W R Levis, et al.Archives of Dermatology|March 1, 1986
Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantarisJ C Vance, B J Bart, R C Hansen, et al.The New England Journal of Medicine|December 23, 1982
The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypesW C Van Voorhis, G Kaplan, E N Sarno, et al.Plant Disease|February 7, 2019
Identification, Virulence, and Distribution of Two Biovars of Pseudomonas syringae pv. actinidiae in New ZealandJ L Vanneste, J Yu, D A Cornish, et al.Archives of Dermatology|November 11, 1992
Treatment of cutaneous squamous cell carcinomas by intralesional interferon alfa-2b therapyL Edwards, B Berman, R P Rapini, et al.Pageof 7